Airway Therapeutics Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Airway Therapeutics's estimated annual revenue is currently $2.5M per year.(i)
  • Airway Therapeutics's estimated revenue per employee is $206,667

Employee Data

  • Airway Therapeutics has 12 Employees.(i)
  • Airway Therapeutics grew their employee count by -8% last year.

Airway Therapeutics's People

NameTitleEmail/Phone
1
President/CEOReveal Email/Phone
2
VP Regulatory Affairs & QualityReveal Email/Phone
3
Controller & Director OperationsReveal Email/Phone
4
Director, Operations Analytics & QualityReveal Email/Phone
5
Director Chemistry Manufacturing and ControlsReveal Email/Phone
6
Assistant Director OperationsReveal Email/Phone
7
Chief Medical OfficerReveal Email/Phone
8
Senior Director, Quality Assurance, Quality Control, and Regulatory AffairsReveal Email/Phone
9
QC AnalystReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.8M3-25%N/AN/A
#2
$1.7M110%N/AN/A
#3
$0.8M40%N/AN/A
#4
$5.1M3314%N/AN/A
#5
$64.6M3636%N/AN/A
#6
$1.7M1011%N/AN/A
#7
$0.8M13225%N/AN/A
#8
$7.4M37-5%N/AN/A
#9
$0.6M30%N/AN/A
#10
$0.9M10-9%N/AN/A
Add Company

What Is Airway Therapeutics?

Created in 2011 as a spin-out of Cincinnati Children's Hospital Medical Center (CCHMC), Airway Therapeutics has extensive expertise in protein development for applications in the lungs and pediatrics. Airway Therapeutics is in advanced preclinical phase of developing AT-100 (rhSP-D), a product targeting bronchopulmonary dysplasia (BPD) in newborns.

keywords:N/A

N/A

Total Funding

12

Number of Employees

$2.5M

Revenue (est)

-8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Airway Therapeutics News

2022-04-19 - Bronchopulmonary Dysplasia Treatment Market Size, Scope ...

... Players – Chiesi Farmaceutici, Meridigen Biotech, Therabron Therapeutics, Airway Therapeutics, MediPost, Syntrix Biosystems, Insmed.

2022-04-19 - Axsome Therapeutics' major depressive disorder drug steps ...

Axsome Therapeutics has agreed to a set of postmarketing conditions that the FDA ... different chronic inflammatory airway conditions including asthma,...

2022-03-30 - Airway Therapeutics Announces First Patient Dosed in Phase ...

Airway Therapeutics is a biopharmaceutical company developing a new class of biologics to break the cycle of injury and inflammation for...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.6M12-14%N/A
#2
N/A12-25%N/A
#3
$2M12-14%N/A
#4
$0.4M1233%N/A
#5
$1M120%N/A